Skip to main content
ILIVER logoLink to ILIVER
. 2022 Oct 28;1(4):217–224. doi: 10.1016/j.iliver.2022.09.004

Establishment of a risk assessment system for complications of hepatectomy based on preoperative variables

Lining Xu a,1, Guiping Li b,1, Bo Yang c,∗
PMCID: PMC12212708  PMID: 40636349

Abstract

Background and aims

To reduce the incidence of postoperative complications, it is important to predict them and intervene before surgery if necessary. However, there is no ideal system to evaluate the overall risk of postoperative complications of liver surgery on the basis of preoperative variables. Therefore, this study aimed to design and validate a risk assessment system to predict postoperative complications of hepatectomy on the basis of preoperative variables.

Methods

Binomial logistic regression was used to derive the “hepatectomy overall risk formula” (HORF) for predicting postoperative complications on the basis of preoperative variables.

Results

Multivariate analysis revealed that Child–Pugh grade B–C (odds ratio [OR] = 1.984, p = 0.002), medical diseases requiring drug treatment (OR = 1.883, p = 0.003), major hepatectomy (OR = 1.947, p < 0.001), adjacent organ invasion (OR = 3.616, p = 0.023), and preoperative hospital stay >7 days (OR = 1.565, p = 0.004) were independent risk factors for postoperative complications of hepatectomy. The area under the curve for the HORF was 0.736. The optimal cut-off value for predicting complications was 0.32 (32%). The area under the curve for the HORF in the validation dataset was 0.727.

Conclusion

The HORF can accurately predict postoperative complications of hepatectomy on the basis of preoperative variables, and thus enables the determination of the necessity for intervention before surgery.

Keywords: Hepatectomy, Complication, Prediction, Preoperative

1. Introduction

Liver surgery is very difficult to master; it requires continuous and arduous practice [1]. In the past 40 years, breakthroughs in applied basic research, inventions and medical devices, as well as the popularization and improvement of minimally invasive techniques, innovative surgical methods, and diagnostic and treatment standards have led to unprecedented developments in traditional liver surgery [2]. Precision hepatectomy has allowed for significant safety improvements. However, hepatectomy is associated with a high incidence of postoperative complications, which can be fatal [3,4]. Estimating the likelihood of complications before the operation, and intervening at an early stage if necessary, is of clinical importance [5,6]. Although several risk assessment systems have been established, their limitations reduce their clinical utility [7]. As such, there is no ideal system to evaluate the likelihood of hepatectomy complications on the basis of perioperative and preoperative factors. Therefore, a new preoperative evaluation tool improving the safety of hepatectomy would be of great value.

In this study, regression analysis was used to derive a formula for predicting postoperative complications, and an optimal cut-off value was identified. The former should improve the accuracy and objectivity of preoperative evaluations.

2. Materials and methods

2.1. Patients

We enrolled perioperative patients who underwent hepatectomy and had complete medical records. Patients who recently underwent unexpected reoperations were excluded from the study. A total of 1732 cases were enrolled between January 1986 and December 2020. Seven hundred and thirty one (42.2%) of whom had benign liver diseases, including hepatic hemangioma and hepatolithiasis; and 1001 patients (57.8%) had malignant liver diseases, including intrahepatic cholangiocarcinoma and hepatocellular carcinoma. The median age was 47 years (range: 2–82 years), and there were 1075 (62.1%) men and 657 (37.9%) women. The patients' baseline characteristics are shown in Table 1. In total, 100 patients selected at random from the overall cohort constituted the validation cohort.

Table 1.

Patient baseline characteristics.

Factors n
General characteristics
 Age (y) 47 (2–82)
 Sex
 Female 657 (37.9%)
 Male 1075 (62.1%)
Comorbidities 243 (14.0%)
Diagnosis
 Malignant diseases 1001 (57.8%)
 Benign diseases 731 (42.2%)
Preoperative evaluation
Blood test
 Albumin (g/L)
 <35 191 (11.0%)
 ≥35 1541 (89.0%)
 Total bilirubin (μmol/L)
 ≤21 1295 (74.8%)
 >21 437 (25.2%)
Child–Pugh grade
 A 1552 (89.6%)
 B–C 180 (10.4%)
Tumor-related factors
Largest tumor size (cm)
 ≤5 899 (51.9)
 5–10 575 (33.2%)
 >10 258 (14.9%)
Number of lesions
 One 1505 (86.9%)
 Multiple 227 (13.1%)
Operative variables
Extent of resection
 Minor hepatectomy 967 (55.8%)
 Major hepatectomy 765 (44.2%)
Resection type
 Nonanatomical 1201 (69.3%)
 Anatomical 531 (30.7%)
Operative duration (min)
 <180 732 (42.3%)
 ≥180 1000 (57.7%)
Intraoperative blood loss (mL)
 ≤800 1516 (87.5%)
 >800 216 (12.5%)
Intraoperative blood transfusion
 No 966 (55.8%)
 Yes 766 (44.2%)

2.2. Data collection

All patients' medical records contained disease history and physical examination data. On the basis of commonly used surgical risk scoring systems and our previous clinical experience, the perioperative factors analyzed were as follows: basic patient characteristics, diagnosis, laboratory examination results, type of surgery, and medical diseases and medication history. Preoperative data included patient demographics, diagnoses, medical diseases medication history, imaging examinations, and laboratory blood analyses (including bilirubin, transaminase, and albumin). Intraoperative data included the extent of resection, estimated blood loss, and operation duration. The postoperative data included hospital length of stay, complications, mortality, and pathology.

2.3. Research methods

2.3.1. Risk factors for postoperative complications

Potential independent risk factors for postoperative complications were included in univariate correlation and multivariate logistic regression analyses. Odds ratios (ORs) were calculated, on the basis of which a scoring system was devised. The risk scores were rounded to the nearest integer for clinical applicability. The sum of the scores for all risk factors was defined as the total risk score. The methods are described in more detail in our previous study [8].

2.3.2. “Hepatectomy overall risk formula” for post-hepatectomy complications

Binomial logistic regression of complications was performed, and the hepatectomy overall risk formula (HORF) was calculated as follows: P = 1/{1 + exp [-(α + β1χ1 + β2χ2 +···+βnχn)]}, where P represents the probability of complications; when P = 1, the probability of complications is 100%. α is a constant term, β1–βn are regression coefficients corresponding to the risk index of complications, and χ1–χn are grades for risk factors.

2.3.3. HORF validation

The HORF was used to score and calculate the probability of complications. The receiver operating characteristic (ROC) curve was used to verify the validity of the HORF, and the cut-off value of the risk index was calculated.

2.4. Statistical analysis

We used SPSS software (ver. 25.0; IBM Corp., Armonk, NY, USA) for the analysis. Continuous variables, such as estimated blood loss and operation duration, were classified into grades/levels. A p-value < 0.05 was considered statistically significant.

3. Results

3.1. Incidence of hepatectomy complications

Of the 1732 patients, 419 (24.19%) patients developed complications, among whom 164 (39.14%) patients had more than two complications. The complications were fatal in 14 cases (3.34% of all cases with complications), yielding a mortality rate of 0.81% (Table 2).

Table 2.

Postoperative complications.

Complication n Ratio relative to the total number of patients
Infection of the abdomen
 Around drainage tube 1 0.06%
 Abdominal cavity 1 0.06%
 Ascitic fluid 1 0.06%
 Intra-abdominal abscess 2 0.12%
 Incisional wound 7 0.4%
 Peri-liver abscess 22 1.27%
Bile duct
 Sclerosing cholangitis 1 0.06%
 Cholangiolitis 5 0.29%
 Biliary tract obstruction 1 0.06%
 Bile leakage 29 1.67%
Bleeding
 Hemobilia 1 0.06%
 Incision bleeding 1 0.06%
 Alimentary tract hemorrhage 17 0.98%
 Abdominal cavity/raw surface bleeding 13 0.75%
Surgical site-related injuries
 Gastric fistula 1 0.06%
 Fistula of anastomosis 3 0.17%
 Pancreatic fistula 2 0.12%
 Incision disruption 10 0.58%
 Wound liquefaction 12 0.69%
Peritoneal effusion
 Pelvic cavity fluid collection 2 0.12%
 Retro-peritoneum fluid collection 1 0.06%
 Sub-diaphragm fluid collection 6 0.35%
 Peri-liver fluid collection (sterile) 90 5.20%
 Ascites 129 7.45%
Liver and kidney injury
 Focal hepatonecrosis 1 0.06%
 Hepatic inadequacy 26 1.50%
 Renal inadequacy 18 1.04%
Pulmonary and cardiovascular
 Pleural cavity infection 1 0.06%
 Thrombosis of vena cava 1 0.06%
 Heart failure 3 0.17%
 Heart infarction 3 0.17%
 Hemorrhagic shock 3 0.17%
 Respiratory tract infection 5 0.29%
 Deep venous thrombosis (lower extremity) 6 0.35%
 Pneumothorax 5 0.29%
 Respiratory insufficiency 13 0.75%
 Atelectasis 26 1.50%
 Pneumonia 32 1.85%
 Pleural effusion 236 13.63%
Others
 Cerebral accident 2 0.12%
 Glottic paralysis 1 0.06%
 Electrolyte disturbances 16 0.92%
 Dislocation of cricoarytenoid articulation 2 0.12%
 Fever of unknown origin 27 1.56%
 Ventricular fibrillation 1 0.06%
 Peritonitis (sterile) 3 0.17%
 Stress ulcer 5 0.29%

3.2. Preoperative clinical risk factors for postoperative complications

In univariate correlation analysis, preoperative clinical factors associated with postoperative liver complications included previous history of surgery (p = 0.019), history of abdominal surgery history without liver surgery (p = 0.011), total bilirubin (p < 0.001), medical diseases requiring drug treatment (p < 0.001), Child–Pugh grade (p < 0.001), extent of resection (p = 0.001), pathological type (p = 0.006), resection type (p < 0.001), adjacent organ invasion (p = 0.002), and preoperative hospital stay (p = 0.005). These clinical factors were all graded. Since bilirubin is among the factors comprising the Child–Pugh grade, it was combined with the Child–Pugh grade in the evaluation system for simplicity and ease of operation (Table 3).

Table 3.

Univariate analysis (chi-squared test) of preoperative clinical factors associated with complications of hepatectomy.

Variable Total (n) Complications (n) p-value
Previous history of surgery 0.019
 Yes 333 97
 No 1399 322
History of abdominal surgery without liver surgery 0.011
 Yes 320 95
 No 1412 324
Total bilirubin (μmol/L) <0.001
 ≤21 1295 255
 >21 437 164
Medical diseases requiring drug treatment <0.001
 Yes 192 138
 No 1489 281
Child–Pugh grade <0.001
 A 1552 349
 B–C 180 70
Extent of resection 0.001
 Minor hepatectomy 967 205
 Major hepatectomy 765 214
Pathological type 0.006
 Malignant 951 220
 Benign 682 199
Resection type <0.001
 Anatomical 531 98
 Nonanatomical 1201 321
Adjacent organ invasion 0.002
 Yes 18 10
 No 1714 409
Preoperative hospital stay (days) 0.005
 ≤7 1203 268
 >7 529 151

Multivariate regression analysis revealed the following independent risk factors for postoperative complications of hepatectomy: Child–Pugh grade B–C (OR = 1.984, p = 0.002), medical diseases requiring drug treatment (OR = 1.883, p = 0.003), major hepatectomy (OR = 1.947, p < 0.001), adjacent organ invasion (OR = 3.616, p = 0.023), and preoperative hospital stay >7 days (OR = 1.565, p = 0.004) (Table 4). On the basis of the ORs for these factors, a new scoring system was devised. The ORs were rounded to the nearest integer for clinical applicability, as follows: Child–Pugh grade B/C, 2 points; medical diseases requiring drug treatment, 2 points; major hepatectomy, 2 points; adjacent organ invasion, 4 points; preoperative hospital stay >7 days, 2 points (Table 5).

Table 4.

Results of logistic regression analysis identifying factors independently influencing post-hepatectomy complications.

Variable Odds ratio p-value Score
χ1:Child–Pugh grade (A/B–C) 1.984 0.002 1/2
χ2:Medical diseases requiring drug treatment (no/yes) 1.883 0.003 1/2
χ3:Extent of resection (minor hepatectomy/major hepatectomy) 1.947 <0.001 1/2
χ4:Adjacent organ invasion (no/yes) 3.616 0.023 1/4
χ5:Preoperative hospital stay (≤7/> 7 days) 1.565 0.004 1/2

Table 5.

Components of the new scoring system.

Variable Level Score
χ1:Child–Pugh grade A 1
B–C 2
χ2:Medical diseases requiring drug treatment No 1
Yes 2
χ3:Extent of resection Minor hepatectomy 1
Major hepatectomy 2
χ4:Adjacent organ invasion No 1
Yes 4
χ5:Preoperative hospital stay (days) ≤7 1
>7 2

Note: the total score was calculated by summing the scores for the five individual variables.

3.3. Establishment of a formula for calculating the risk of complications of hepatectomy

A binomial logistic regression model was established with the risk scores (for hepatectomy complications) of preoperative factors as independent variables and occurrence of complications as the dependent variable. The intercepts (regression coefficients) are shown in Table 6. The formula for calculating the risk of complications was as follows:

P = 1/{1 + exp [-(-4.844 + 0.737χ1 + 0.530χ2 + 0.673χ3 + 0.412χ4 + 0.464χ5)]}

Table 6.

Logistic regression coefficients of factors associated with hepatectomy complications.

Variable Intercept Wald statistic
χ1:Child–Pugh grade (B–C/A) 0.737 (β1) 14.530
χ2:Medical diseases requiring drug treatment (no/yes) 0.530 (β2) 7.235
χ3:Extent of resection (minor hepatectomy/major hepatectomy) 0.673 (β3) 26.759
χ4:Adjacent organ invasion (no/yes) 0.412 (β4) 5.299
χ5:Preoperative hospital stay (≤7/> 7 days) 0.464 (β5) 11.809
Constant −4.844(α) 144.346

3.4. Predictive ability of the combined variables

The ROC curves for each factor are plotted in Fig. 1. The ROC curve of the five variables combined is shown in Fig. 2A; the area under the curve (AUC) was 0.735 (standard error = 0.015). The total score was calculated by summing the scores for all factors. The optimal cut-off total score for postoperative complications was 6.5; the incidence of postoperative complications was significantly different between groups with ≤6 and ≥7 points (χ2 = 59.217, p < 0.001), as shown in Fig. 2B.

Fig. 1.

Fig. 1

Predictive ability of the five variables. Blue line, Child–Pugh grade; purple line, medical diseases requiring drug treatment; green line, number of segments resected; red line, adjacent organ invasion; yellow line, preoperative hospital stay. The area under the curve values for postoperative complication were 0.596, 0.579, 0.620, 0.514, and 0.611 for Child–Pugh grade, medical diseases requiring drug treatment, extent of resection, adjacent organ invasion, and preoperative hospital stay, respectively.

Fig. 2.

Fig. 2

(A) Predictive ability of the combined variables (area under the curve = 0.735). (B) Incidence of complications. The incidence of complications in the group with ≤6 points on the new scoring system was significantly lower than that in the group with ≥7 points (p < 0.001).

3.5. Predictive ability of the HORF

The scores for each variable and patient were substituted into the HORF to calculate the expected probability of complications, and an ROC curve was generated to evaluate the predictive ability, as shown in Fig. 3. The AUC of the HORF was 0.736 (standard error = 0.016). The optimal cut-off value for predicting complications was 0.32 (32%).

Fig. 3.

Fig. 3

Predictive ability of the hepatectomy overall risk formula (HORF). The area under the curve for the HORF was 0.736.

3.6. Validation of the HORF

An ROC curve analysis was used to validate the HORF. The AUC of the HORF was 0.727, as shown in Fig. 4.

Fig. 4.

Fig. 4

Validation of the hepatectomy overall risk formula (HORF). The area under the curve of the HORF was 0.727.

3.7. Study flow chart

A flowchart of this study is shown in Fig. 5.

Fig. 5.

Fig. 5

Study flow chart.

4. Discussion

The safety of hepatectomy has always been an important consideration in liver surgery [9]. The morbidity and mortality rates of hepatectomy remain high, and improving preoperative prevention strategies to reduce the incidence of postoperative complications is a difficult task [10]. Unfortunately, there is still no intuitive and accurate system to predict hepatectomy complications on the basis of preoperative factors [11]. Therefore, in this study, we established a preoperative risk prediction and evaluation system for hepatectomy complications to aid interventions in high-risk patients before surgery, and thus improve the safety of liver surgery.

Liver failure after hepatectomy is an important cause of death [12]. Precise assessment of liver function is crucial for hepatectomy, where the balance between the operative procedure and remnant liver function is the most important concern for patients with chronic liver disease [13]. The Child–Pugh grade is the most widely used method for evaluating liver function [14]. In this study, the Child–Pugh grade was an independent risk factor for complications after hepatectomy. However, due to the subjectivity of some indicators, the Child–Pugh grade alone is insufficient to accurately predict postoperative liver complications; other indicators should also be used.

Many patients who require surgery have one or more additional medical conditions, termed comorbidities [15]. Comorbidities, which are particularly common in elderly individuals, can affect disease manifestations and severity, and sometimes impact management [16]. Old age and its attendant risks are the major predisposing factors for poor postoperative outcomes [17]. With the development of traditional surgery, a large number of high-risk surgery patients with single or multiple organ dysfunctions have undergone surgery, and the number of surgical patients with atherosclerosis, diabetes, chronic obstructive pulmonary disease, and other internal diseases has increased rapidly. In this study, concomitant medical condition requiring medication was an independent risk factor for postoperative complications of hepatectomy. Although the rate of comorbidities gradually increased with age in our cohort, our results do not suggest that age is related to complications. The incidence of complications was low among the elderly surgical patients without comorbidities, indicating that comorbidities was the decisive factor in terms of complications, rather than age.

Giant liver tumors, which were considered inoperable in the past, have been safely resected in recent years, mainly due to improvements in surgical techniques and perioperative management [4]. For an optimal perioperative strategy, the measurement of vital signs, maintenance of electrolyte balance and normal function of vital organs, and intraoperative application of aseptic dressings, hemostatic dressings, and sutures is essential. However, the amount of hepatectomy (residual functional liver volume) remains the most important factor in terms of liver dysfunction after hepatectomy [18]. This study showed that more extensive resection was an independent risk factor for complications after hepatectomy. Similarly, many studies have shown that the more extensive the operation, the more likely it is that complications will occur. Among our patients with extrahepatic organ invasion, the risk of complications was greater when organ resection was performed simultaneously.

The length of the preoperative hospital stay was correlated with illness severity in this study; the more severe the illness, the more complicated the preoperative preparation and the longer the hospital stay. In contrast, in uncomplicated cases with few comorbidities, preoperative preparation is simple and short. In this study, multivariate analysis showed that preoperative hospital stay was independently associated with postoperative complications of liver surgery.

Chen et al. [11] established a simplified scoring system based on perioperative parameters including diabetes, the extent of surgery, the serum potassium level, and blood loss relative to body weight. However, blood loss is an intraoperative measure that can only be assessed at the end of the operation, such that their scoring system cannot be used to evaluate the risk of postoperative complications preoperatively. Our HORF can predict the occurrence of postoperative complications using only preoperative indexes, and thus provides a basis for preoperative intervention. Donadon et al. [19] established the Humanitas score for individualized risk estimation of postoperative morbidity after hepatectomy. This scoring system includes the following indicators: major hepatectomy, liver stiffness, the BILCHE score, and esophageal varices. However, as a limitation, liver stiffness is not typically examined in the clinical setting; some hospitals do not perform this examination, which limits the applicability of this scoring system. Similarly, the BILCHE score is not often used in clinical practice, and the clinical utility of cholinesterase is limited compared with the Child–Pugh grade. Finally, the diagnosis of esophageal varices can only be confirmed by upper gastrointestinal endoscopy, which is complicated and causes great discomfort to patients.

Some limitations of this study should also be noted. First, due to limitations in terms of the researchers, case screening, and available time, among other factors, the HORF was subjected to internal validation rather than the more powerful external validation. However, due to the large sample size, the validation results can be considered reliable. We are planning future research to further refine the HORF.

In this study, a binomial logistic regression model was established to obtain the HORF, which allows assessment of the risk of complications of hepatectomy. As a novel and simple assessment system, the HORF can be used to effectively predict postoperative complications of hepatectomy before surgery, i.e., on the basis of preoperative factors.

Funding

This study was supported by the General Project of Natural Science Foundation of Hubei Province (2020CFB826).

Author contributions

Xu L, Li G, and Yang B designed the research, performed the primary literature search, and extracted the data. Xu L analyzed the data, Yang B wrote the manuscript, and Xu L, Li G, and Yang B were responsible for revising the manuscript for important intellectual content. All authors read and approved the final version of the manuscript.

Acknowledgments

The authors thank Mrs. Guang Yang for her assistance with the data collection.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Data available statement

The patient data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Ethics statement

This study was approved by the ethics committee of Chinese PLA General Hospital. All patients provided informed consent. This study was performed according to the ethical standards of the Declaration of Helsinki.

Informed consent

This study used deidentified patient information and was conducted in accordance with the principle of informed consent.

References

  • 1.Rashidian N., Vierstraete M., Alseidi A., et al. Surgical education interventions in liver surgery: a systematic review. Updates Surg. 2020;72(3):583–594. doi: 10.1007/s13304-020-00766-x. [DOI] [PubMed] [Google Scholar]
  • 2.Zhang W., Chen X.P. Current status and prospect of liver surgery. Zhonghua Wai Ke Za Zhi. 2019;57(7):488–493. doi: 10.3760/cma.j.issn.0529-5815.2019.07.002. [DOI] [PubMed] [Google Scholar]
  • 3.Cai X.J., Zheng Q., Jiang G.Y. Current status and prospect of surgical treatment of liver cancer. Zhonghua Wai Ke Za Zhi. 2019;57(7):494–499. doi: 10.3760/cma.j.issn.0529-5815.2019.07.003. [DOI] [PubMed] [Google Scholar]
  • 4.Orcutt S.T., Anaya D.A. Liver resection and surgical strategies for management of primary liver cancer. Cancer Control. 2018;25(1) doi: 10.1177/1073274817744621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ge P.L., Du S.D., Mao Y.L. Advances in preoperative assessment of liver function. Hepatobiliary Pancreat Dis Int. 2014;13(4):361–370. doi: 10.1016/s1499-3872(14)60267-8. [DOI] [PubMed] [Google Scholar]
  • 6.Shi J.Y., Sun L.Y., Quan B., et al. A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2021;45(4) doi: 10.1016/j.clinre.2020.09.001. [DOI] [PubMed] [Google Scholar]
  • 7.Longchamp G., Labgaa I., Demartines N., et al. Predictors of complications after liver surgery: a systematic review of the literature. HPB. 2021;23(5):645–655. doi: 10.1016/j.hpb.2020.12.009. [DOI] [PubMed] [Google Scholar]
  • 8.Xu L.N., Xu Y.Y., Li G.P., et al. Individualized risk estimation for postoperative pulmonary complications after hepatectomy based on perioperative variables. World J Gastrointest Surg. 2022;14(7):685–695. doi: 10.4240/wjgs.v14.i7.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jiang J., Pei L., Jiang R. Clinical efficacy and safety of 3D vascular reconstruction combined with 3D navigation in laparoscopic hepatectomy: systematic review and meta-analysis. J Gastrointest Oncol. 2022;13(3):1215–1223. doi: 10.21037/jgo-22-198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Xu L.N., Xu Y.Y., Gao D.W. Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy. J Huazhong Univ Sci Technolog M ed Sci. 2016;36(4):523–528. doi: 10.1007/s11596-016-1619-2. [DOI] [PubMed] [Google Scholar]
  • 11.Chen L., Wang Y.B., Zhang Y.H., et al. Effective prediction of postoperative complications for patients after open hepatectomy: a simplified scoring system based on perioperative parameters. BMC Surg. 2019;19(1):128. doi: 10.1186/s12893-019-0597-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Søreide J.A., Deshpande R. Post hepatectomy liver failure (PHLF) - recent advances in prevention and clinical management. Eur J Surg Oncol. 2021;47(2):216–224. doi: 10.1016/j.ejso.2020.09.001. [DOI] [PubMed] [Google Scholar]
  • 13.Yamazaki S., Takayama T. Management strategies to minimize mortality in liver resection for hepatocellular carcinoma. Jpn J Clin Oncol. 2017;47(10):899–908. doi: 10.1093/jjco/hyx104. [DOI] [PubMed] [Google Scholar]
  • 14.Rimini M., Rovesti G., Casadei-Gardini A. Child Pugh and ALBI grade: past, present or future? Ann Transl Med. 2020;8(17):1044. doi: 10.21037/atm-20-3709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Couri T., Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13(2):125–137. doi: 10.1007/s12072-018-9919-1. [DOI] [PubMed] [Google Scholar]
  • 16.Scichilone N. Comorbidities of lung disease in the elderly. Clin Geriatr Med. 2017;33(4):597–603. doi: 10.1016/j.cger.2017.06.010. [DOI] [PubMed] [Google Scholar]
  • 17.Olotu C. Anesthesia for the elderly: a narrative review. Minerva Anestesiol. 2021;87(10):1128–1138. doi: 10.23736/S0375-9393.21.15388-X. [DOI] [PubMed] [Google Scholar]
  • 18.Cassese G., Han H.S., Al Farai A., et al. Future remnant liver optimization: preoperative assessment, volume augmentation procedures and management of PVE failure. Minerva Surg. 2022;77(4):368–379. doi: 10.23736/S2724-5691.22.09541-7. [DOI] [PubMed] [Google Scholar]
  • 19.Donadon M., Fontana A., Palmisano A., et al. Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score. HPB. 2017;19(10):910–918. doi: 10.1016/j.hpb.2017.06.009. [DOI] [PubMed] [Google Scholar]

Articles from ILIVER are provided here courtesy of Elsevier

RESOURCES